1[1]Zhang Y,Telenti A.Genetics of drug resistance in Mycobacterium tuberculosis In:Molecular Genetics of Mycobacteria.Edited by Hatful GF,Jacobs WR Jr.ASM Press,2000:235-254.
2[2]Jin D J,Gross C A.Mapping and sequencing of mutations in the Escherichla coli.RpoB gene that lead to rifampicin tesistance.J Mol Biol,1988;202:45-48.
3[3]Miller L P,Crawford J T,Shinnick T M.The rpoB gene of Mycobacterium tuberculosis.Antimicrob Agents Chemother,1994 ;38:805-811.
4[4]Scorpio A,Zhang Y.Mutations in pncA,a gene encoding pyrazinamidase/nicotinamidase,cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.Nature Med,1996 ;2:662-667.
6[6]Cole ST,Brosch R,Parkhill J,et al.Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.Nature,1998; 393:537-544.
7[7]Heifets L B,Lindholnr Levy P F,Iseman M D.Rifambutin:minimal inhibitory and bactericidal concentrations for mycobacterium tuberculosis.Am Respir Crit Care Med,1995; 151:942-945.
8[9]Mor N,Vanderkolk J,Heifets L.Inhibitory and bactericidal activities of levofloxacin against mycobacterium tuberculosis in vitro and in human macrophage.Antimicrob Agents Chemother,1994 ;38:1161-1164.
9[10]Joia S Mukherjee.Programe and principle on therapy of multidrug-resistant Mycobacterium tuberculosis.Lancet,2004 ;363:474-481.
10[11]Miyaz aki E,Miyazaki M,Chen JM,et al.Moxifloxacin (BAY12-8039),a new 8-methoxyquinolone,is active in a mouse model of tuberculosis.Antimicrob Agents Chemother,1999 ;43:85-9.
